Physicians registered with the Drug Enforcement Administration will no longer need to meet the X-waiver requirement to prescribe treatments such as buprenorphine for opioid use disorder, the Department of Health and Human Services announced yesterday.

HHS said it will publish updates to its Practice Guidelines for the Administration of Buprenorphine for Treating Opioid Use Disorder that expands access to medication-assisted treatment by exempting physicians from certain certification requirements.

The exemptions apply to physicians treating patients in states where they are authorized to practice medicine; physicians, meanwhile, will be limited to treating 30 patients with buprenorphine for OUD at any one time, not including hospital-based physicians, such as those in emergency departments.

The new policy applies only to the prescription of drugs or formulations covered under the X-waiver and physicians must place an "X" on the prescription, which must clearly identify it as being written for OUD.

 

 

Related News Articles

Headline
Oct. 28 is National Prescription Drug Take Back Day, an opportunity for the public to safely dispose of unwanted or expired tablets, capsules, patches and…
Headline
Federal agencies last month stopped over 500 unapproved pharmaceutical products and medical devices, including opioid and other controlled substances, from…
Headline
As the House Energy and Commerce Committee works to reauthorize key programs within the Substance Use-Disorder Prevention that Promotes Opioid Recovery and…
Headline
While counseling and other services are an important part of a comprehensive treatment plan for opioid use disorder, the provision of medication should not be…
Headline
AHA today launched an updated Opioid Stewardship Hub, featuring the latest tools and resources to help hospitals and health systems address the opioid epidemic…
Headline
The Food and Drug Administration last week required certain labeling updates for opioid pain medicines in an effort to reduce unnecessary prescribing and…